Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Maintenance Lipo-Dox + carboplatin versus observation in advanced ovarian cancer after complete remission
ACTRN12607000329460Phase 3Completed
- Sponsor
- Chang Gung Memorial Hospital
- Start
- Jun 2007
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
- Countries
- 2
01
Overview
Phase 3, randomised, open-label trial in ovarian cancer comparing Maintenance Lipo-Dox + carboplatin with Observation (2 arms). Primary endpoint: Progression-free survival. Started Jun 2007; status: completed.
02
Drugs
pegylated liposomal doxorubicincarboplatin
03
Conditions
ovarian cancer
Beyond the preview
Go deeper on ACTRN12607000329460.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12607000329460.